Aarti Pharma Labs

907.30
+2.85
(0.32%)
Market Cap
8,223.28 Cr
EPS
30.06
PE Ratio
30.07
Dividend Yield
0.55 %
Industry
Healthcare
52 Week High
949.50
52 Week Low
551.05
PB Ratio
4.12
Debt to Equity
0.15
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,679.20
#1 4,02,896.33
35.11
#1 52,041.20
12.06
#1 10,980
-18.99
49.60
6,911.50
1,83,478.61
83.20
9,360.00
0.89
2,117
23.05
67.24
1,516.10
1,22,456.58
23.68
28,409.50
7.12
5,291
30.28
52.75
3,369.00
1,14,022.27
58.56
11,317.00
11.59
2,054
10.91
59.08
1,294.60
1,08,043.57
19.45
33,741.20
12.36
5,725
21.14
49.51
2,460.60
1,01,556.04
49.11
12,207.40
19.57
1,925
-10.91
49.97
1,006.70
1,01,297.58
21.53
22,573.80
13.82
3,977
-0.19
69.48
1,990.00
90,882.40
27.22
22,192.10
#1 19.94
3,024
#1 112.49
47.26
34,930.00
74,223.81
53.31
6,409.15
10.80
1,417
27.83
71.69
1,191.20
69,185.09
#1 19.42
31,378.10
17.55
3,366
-0.50
55.14
Forecast
Actual
Growth Rate
Revenue Growth
-4.63 %
Net Income Growth
12.09 %
Cash Flow Change
-13.50 %
ROE
-0.64 %
ROCE
-1.87 %
EBITDA Margin (Avg.)
19.06 %

Quarterly Financial Results

Quarterly Financials
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Revenue
463
457
532
472
486
459
441
450
508
558
463
543
562
Expenses
385
371
441
385
405
374
352
353
388
459
364
409
418
EBITDA
78
86
91
87
81
85
89
97
120
99
98
134
144
Operating Profit %
16 %
19 %
17 %
18 %
16 %
19 %
20 %
21 %
23 %
17 %
20 %
24 %
26 %
Depreciation
14
14
17
16
16
17
18
19
19
20
21
23
23
Interest
5
4
6
5
6
4
4
5
5
5
6
10
7
Profit Before Tax
60
68
69
65
59
64
67
74
96
74
72
101
115
Tax
11
16
18
17
16
17
15
21
31
18
17
27
26
Net Profit
49
52
51
48
43
47
52
53
65
56
55
74
88
EPS in ₹
5.39
5.72
5.64
5.26
4.73
5.20
5.72
5.82
7.20
6.12
6.03
8.16
9.75

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
Total Assets
0
2,040
2,244
2,582
2,906
Fixed Assets
0
782
926
1,033
1,509
Current Assets
0
1,028
1,163
1,346
1,322
Capital Work in Progress
0
187
102
137
307
Investments
0
32
87
107
588
Other Assets
0
1,038
1,130
1,305
0
Total Liabilities
0
2,040
2,244
2,582
2,906
Current Liabilities
0
581
601
694
657
Non Current Liabilities
0
73
85
131
260
Total Equity
0
1,387
1,559
1,757
1,990
Reserve & Surplus
0
1,341
1,513
1,712
1,945
Share Capital
0
0
45
45
45

Cash Flow

Cash Flow
2021
2022
2023
2024
Net Cash Flow
0
78
-71
12
Investing Activities
0
-139
-158
-215
Operating Activities
0
-44
250
216
Financing Activities
0
260
-164
10

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2 3 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.46 0.4 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
10 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
10 May 2025 735.15 767.35
14 Feb 2025 DIVIDEND Dividend
₹ 2.50 /share
14 Feb 2025 637.55 718.85
05 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
05 Feb 2025 585.15 637.55
28 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Oct 2024 601.50 630.70
07 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
07 Aug 2024 606.90 597.00
31 Jul 2024 DIVIDEND Dividend
₹ 1.00 /share
31 Jul 2024 520.20 632.40
19 Feb 2024 DIVIDEND Dividend
₹ 2.00 /share
16 Feb 2024 557.85 533.45

Announcements

Closure of Trading Window8 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 18, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 20, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 16, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 12, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 12, 2025
Grant Of Options Under PSOP Scheme 2023May 10, 2025
Announcement under Regulation 30 (LODR)-Dividend UpdatesMay 10, 2025
Results For The Financial Year Ended 31.03.2025May 10, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Dated 10 May 2025May 10, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 05, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 29, 2025
Board Meeting Intimation for Audited Financial Results For The Year Ended March 31 2025 And Recommendation Of Dividend If Any For The Financial Year Ended March 31 2025.Apr 25, 2025
Intimation Of Change In Email And Website Address Of Registrar And Share Transfer Agent (RTA)Apr 18, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 08, 2025
Announcement under Regulation 30 (LODR)-Joint VentureApr 01, 2025
Closure of Trading WindowMar 20, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSMar 10, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 07, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 07, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 06, 2025
Record Date For Interim DividendFeb 05, 2025
Corporate Action-Board to consider DividendFeb 05, 2025
Integrated Filing (Financial)Feb 05, 2025
Financial Results For Quarter Ended December 31 2024Feb 05, 2025
Board Meeting Outcome for Financial Results For Quarter Ended December 31 2024Feb 05, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 28, 2025
Board Meeting Intimation for Audited Financial Results Of The Company For The Quarter And Nine-Months Ended December 31 2024 And 2. Declaration Of Interim Dividend If Any On The Equity Share Capital OJan 28, 2025
Re-Opening Of Manufacturing Activities At The CompanyS Vapi PlantJan 18, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 10, 2025
Announcement under Regulation 30 (LODR)-AcquisitionJan 09, 2025
Closure Of Manufacturing Activities At The CompanyS Vapi PlantJan 03, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 30, 2024
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Dec 30, 2024
Disclosure under Regulation 30A of LODRDec 17, 2024
Board Meeting Outcome for Outcome Of Board MeetingDec 13, 2024
Appointment of Company Secretary and Compliance OfficerDec 13, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 10, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 04, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationOct 29, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeOct 28, 2024
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance OfficerOct 28, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationOct 28, 2024
Board Meeting Outcome for Financial Results For The Quarter And Half Year Ended September 30, 2024Oct 28, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationOct 21, 2024
Board Meeting Intimation for Financial Results For Quarter And Half Year Ended September 30, 2024Oct 21, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 08, 2024

Technical Indicators

RSI(14)
Neutral
57.12
ATR(14)
Less Volatile
33.42
STOCH(9,6)
Neutral
61.49
STOCH RSI(14)
Neutral
77.48
MACD(12,26)
Bullish
0.05
ADX(14)
Strong Trend
29.17
UO(9)
Bearish
41.77
ROC(12)
Uptrend And Accelerating
5.27
WillR(14)
Neutral
-27.09